• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4605772)   Today's Articles (4812)   Subscriber (49373)
For: Yang Y, Zhang Y, Miao Z, Zou J, Luo J. miR-22Inhibits CD34+Cell Expansion Through Decreasing β-Catenin in Osteoblasts. Hum Gene Ther 2017;28:135-145. [DOI: 10.1089/hum.2016.104] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]  Open
Number Cited by Other Article(s)
1
Chen G, Zhang X, Chen H, Lin H, Wu H, Lin H, Huang G. miR‐22 represses osteoblast viability with ESR1 presenting a direct target and indirectly inactivating p38 MAPK/JNK signaling. J Gene Med 2020;22:e3174. [PMID: 32056303 DOI: 10.1002/jgm.3174] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Revised: 02/11/2020] [Accepted: 02/12/2020] [Indexed: 12/16/2022]  Open
2
Zhang C, Fang L, Liu X, Nie T, Li R, Cui L, Wang J, Ji Y. miR-22 inhibits synovial fibroblasts proliferation and proinflammatory cytokine production in RASF via targeting SIRT1. Gene 2020;724:144144. [DOI: 10.1016/j.gene.2019.144144] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2019] [Revised: 09/21/2019] [Accepted: 09/23/2019] [Indexed: 12/27/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA